Stockreport

NeuroSense Therapeutics Announces $5 Million Private Placement at Premium to Market Price [Yahoo! Finance]

NeuroSense Therapeutics Ltd.  (NRSN) 
PDF developing novel treatments for severe neurodegenerative diseases, today announced the entry into a definitive agreement with a single investor and with NeuroSense's Chi [Read more]